Clinical Scorecard: Diagnostic Dilemmas in Late-Onset ATTRv: A Case Study of Peripheral Neuropathy Accompanied by Hoarseness and Cough

At a Glance

Key Highlights

• Late-onset ATTRv can present with atypical symptoms such as hoarseness and cough.
• Diagnosis often delayed due to clinical heterogeneity and misdiagnosis.
• Integration of cardiac imaging and genetic screening is crucial for timely diagnosis.
• The p.Ala117Ser mutation is prevalent in specific geographic regions.
• Symptoms may include peripheral neuropathy, gastrointestinal issues, and autonomic dysfunction.

Guideline-Based Recommendations

Diagnosis

• Consider genetic testing for TTR mutations in patients with unexplained peripheral neuropathy.
• Utilize cardiac imaging techniques to assess for amyloid deposition.

Management

• Address symptomatic treatment for neuropathy and associated symptoms.
• Monitor cardiac function and manage any identified cardiac involvement.

Monitoring & Follow-up

• Regular follow-up for progression of neuropathy and cardiac symptoms.
• Assess autonomic function periodically.

Risks

• Delayed diagnosis can lead to worsening symptoms and complications.
• Potential for misdiagnosis as CIDP or CIAP.

Patient & Prescribing Data

Patients with late-onset hereditary transthyretin amyloidosis.

Symptomatic treatments may include medications for neuropathic pain and gastrointestinal symptoms.

Clinical Best Practices

• Maintain a high index of suspicion for ATTRv in patients with unexplained neuropathy.
• Incorporate multidisciplinary evaluations to address atypical symptoms.
• Educate healthcare providers about the atypical presentations of ATTRv.

Related Resources & Content

• Hereditary transthyretin amyloidosis overview
• Clinical manifestations of TTR mutations